Inhibition of human breast cancer Matrigel invasion by Streptolysin O activation of the EGF receptor ErbB1

Cellular Signalling

Volumn 23, Issue 12, 2011, Pages 1972-1977

  Hall, Emily H ^a   Gurel, Volkan ^b   Dahlberg, Albert E ^c   McMichael, John ^b   Brautigan, David L ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

^b Beech Tree Labs Inc   (United States)

^c BROWN UNIVERSITY   (United States)

Author keywords

Breast cancer; Cell invasion; EGFR; Receptor Tyr kinases; RTK array

Indexed keywords

EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; MATRIGEL; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN KINASE B; SMALL INTERFERING RNA; STREPTOLYSIN O;

ARTICLE; BREAST CANCER; CANCER CELL; CELL GROWTH; CELL INVASION; CELL INVASION INHIBITION; CONCENTRATION RESPONSE; CONTROLLED STUDY; EXTRACELLULAR MATRIX; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

BACTERIAL PROTEINS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL MIGRATION ASSAYS; CELL MOVEMENT; COLLAGEN; DRUG COMBINATIONS; EPIDERMAL GROWTH FACTOR; FEMALE; GENE EXPRESSION; GENE KNOCKDOWN TECHNIQUES; GENES, NEOPLASM; HUMANS; LAMININ; MAP KINASE SIGNALING SYSTEM; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; PHOSPHORYLATION; PROTEOGLYCANS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RNA INTERFERENCE; STREPTOLYSINS;

STREPTOCOCCUS SP. 'GROUP A';

EID: 80053243510     PISSN: 08986568     EISSN: 18733913     Source Type: Journal    
DOI: 10.1016/j.cellsig.2011.07.007     Document Type: Article

References (17)

1. Alouf J.E. Pharmacol. Ther. 1980, 11(3):661-717.
2. Bhakdi S., Tranum-Jensen J., Sziegoleit A. Infect. Immun. 1985, 47(1):52-60.
3. Bhakdi S., Bayley H., Valeva A., Walev I., Walker B., Kehoe M., Palmer M. Arch. Microbiol. 1996, 165(2):73-79.
4. Mamber S.W., Long V., Rhodes R.G., Pond-Tor S., Wheeler L.R., Fredericks K., Vanscoy B., Sauniere J.F., Steinschneider R., Laurent J.C., McMichael J. Nonlinearity Biol. Toxicol. Med. 2004, 2(2):67-87.
5. Hall E.H., Balsbaugh J.L., Rose K.L., Shabanowitz J., Hunt D.F., Brautigan D.L. Mol. Cell Proteomics 2010, 9(12):2853-2863.
6. Molhoek KR SA, Smolkin M, Chowbina S, Papin J, Brautigan DL and Slingluff Jr., CL, Melanoma Res. 21 (4) (2011) 274-284.
7. Zhang Y.X., Knyazev P.G., Cheburkin Y.V., Sharma K., Knyazev Y.P., Orfi L., Szabadkai I., Daub H., Keri G., Ullrich A. Cancer Res. 2008, 68(6):1905-1915.
8. Kimura F., Iwaya K., Kawaguchi T., Kaise H., Yamada K., Mukai K., Matsubara O., Ikeda N., Kohno N. Cancer Sci. 2010, 101(5):1133-1140.
9. Price J.T., Tiganis T., Agarwal A., Djakiew D., Thompson E.W. Cancer Res. 1999, 59(21):5475-5478.
10. Shao Z.M., Wu J., Shen Z.Z., Barsky S.H. Anticancer. Res. 1998, 18(3A):1435-1439.
11. Trusolino L., Cavassa S., Angelini P., Ando M., Bertotti A., Comoglio P.M., Boccaccio C. FASEB J. 2000, 14(11):1629-1640.
12. Wang S.J., Saadi W., Lin F., Minh-Canh Nguyen C., Li Jeon N. Exp. Cell Res. 2004, 300(1):180-189.
13. Azios N.G., Dharmawardhane S.F. Neoplasia 2005, 7(2):128-140.
14. Roberts P.J., Der C.J. Oncogene 2007, 26(22):3291-3310.
15. Keshet Y., Seger R. Methods Mol. Biol. 2010, 661:3-38.
16. Procaccia S., Kraus S., Seger R. Methods Mol. Biol. 2010, 661:39-58.
17. Hollestelle A., Elstrodt F., Nagel J.H., Kallemeijn W.W., Schutte M. Mol. Cancer Res. 2007, 5(2):195-201.